AU2003242647B2 - Use of amide derivative of GE 2270 factor A3 for the treatment of acne - Google Patents

Use of amide derivative of GE 2270 factor A3 for the treatment of acne Download PDF

Info

Publication number
AU2003242647B2
AU2003242647B2 AU2003242647A AU2003242647A AU2003242647B2 AU 2003242647 B2 AU2003242647 B2 AU 2003242647B2 AU 2003242647 A AU2003242647 A AU 2003242647A AU 2003242647 A AU2003242647 A AU 2003242647A AU 2003242647 B2 AU2003242647 B2 AU 2003242647B2
Authority
AU
Australia
Prior art keywords
acne
compound
skin
formula
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003242647A
Other languages
English (en)
Other versions
AU2003242647A1 (en
Inventor
Marco Cavaleri
Daniela Jabes
Adriano Malabarba
Giorgio Mosconi
Gabriella Romano'
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naicons SCARL
Original Assignee
Naicons SCARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naicons SCARL filed Critical Naicons SCARL
Publication of AU2003242647A1 publication Critical patent/AU2003242647A1/en
Assigned to NAICONS S.C.A.R.L. reassignment NAICONS S.C.A.R.L. Request for Assignment Assignors: VICURON PHARMACEUTICALS INC.
Application granted granted Critical
Publication of AU2003242647B2 publication Critical patent/AU2003242647B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003242647A 2002-06-17 2003-06-06 Use of amide derivative of GE 2270 factor A3 for the treatment of acne Ceased AU2003242647B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02013268 2002-06-17
EP02013268.4 2002-06-17
PCT/EP2003/005989 WO2003105881A1 (fr) 2002-06-17 2003-06-06 Utilisation de derives amido du ge 2270 facteur a3 pour le traitement de l'acne

Publications (2)

Publication Number Publication Date
AU2003242647A1 AU2003242647A1 (en) 2003-12-31
AU2003242647B2 true AU2003242647B2 (en) 2009-10-22

Family

ID=29724391

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242647A Ceased AU2003242647B2 (en) 2002-06-17 2003-06-06 Use of amide derivative of GE 2270 factor A3 for the treatment of acne

Country Status (18)

Country Link
US (1) US7655676B2 (fr)
EP (1) EP1553967B1 (fr)
JP (1) JP4723857B2 (fr)
KR (1) KR20050026401A (fr)
AR (1) AR039682A1 (fr)
AT (1) ATE509633T1 (fr)
AU (1) AU2003242647B2 (fr)
BR (1) BR0305070A (fr)
CA (1) CA2489705C (fr)
CY (1) CY1111734T1 (fr)
DK (1) DK1553967T3 (fr)
ES (1) ES2364269T3 (fr)
HK (1) HK1074402A1 (fr)
NO (1) NO333162B1 (fr)
PT (1) PT1553967E (fr)
SI (1) SI1553967T1 (fr)
TW (1) TWI329650B (fr)
WO (1) WO2003105881A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20121011A1 (es) * 2006-05-31 2012-08-25 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
MX2009006745A (es) 2006-12-20 2009-08-19 Novartis Ag Macrociclos de amino-tiazol, su uso como compuestos anti-bacterianos y procesos para su produccion.
BRPI0812340A2 (pt) * 2007-06-04 2015-01-27 Novartis Ag Macrociclos e seus usos
BRPI0821138A2 (pt) 2007-12-12 2015-06-16 Novatis Ag Aminotiazóis e seus usos
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
FR3004939B1 (fr) * 2013-04-26 2015-05-22 Oreal Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
DE102013215828A1 (de) * 2013-08-09 2015-02-12 Beiersdorf Ag Gelförmiges Sonnenschutzmittel mit Fettalkoholen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494078A1 (fr) * 1991-01-03 1992-07-08 GRUPPO LEPETIT S.p.A. Amides de l'antibiotique GE2270
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E
US6143739A (en) * 1995-02-07 2000-11-07 Biosearch Italia S.P.A. Basic proline-amide derivatives of GE 2270 and GE 2270-like antibiotics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86865A1 (fr) * 1987-05-06 1989-01-19 Oreal Nouveaux retinoates d'ammonium quaternaires,leur utilisation en cosmetique et en dermopharmacie
ATE86611T1 (de) * 1987-06-12 1993-03-15 Molecular Design Int Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ATE117724T1 (de) * 1989-07-04 1995-02-15 Lepetit Spa Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
JP2693859B2 (ja) * 1990-09-28 1997-12-24 高砂香料工業株式会社 尋常性▲ざ▼瘡用皮膚外用剤
JP2907640B2 (ja) 1992-06-29 1999-06-21 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
JP2937667B2 (ja) * 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US6009225A (en) * 1998-05-26 1999-12-28 Ray; Craig D. Fiber optic drop splice closure and related methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494078A1 (fr) * 1991-01-03 1992-07-08 GRUPPO LEPETIT S.p.A. Amides de l'antibiotique GE2270
US6143739A (en) * 1995-02-07 2000-11-07 Biosearch Italia S.P.A. Basic proline-amide derivatives of GE 2270 and GE 2270-like antibiotics
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Panzer et al. Cutis, Excerpta Medica 1977, 19(1), 109-111 *

Also Published As

Publication number Publication date
WO2003105881A1 (fr) 2003-12-24
CA2489705A1 (fr) 2003-12-24
JP4723857B2 (ja) 2011-07-13
AR039682A1 (es) 2005-03-09
BR0305070A (pt) 2004-09-21
NO20040662L (no) 2004-04-05
JP2005529947A (ja) 2005-10-06
ATE509633T1 (de) 2011-06-15
US20070117825A1 (en) 2007-05-24
NO333162B1 (no) 2013-03-25
TWI329650B (en) 2010-09-01
TW200402425A (en) 2004-02-16
CY1111734T1 (el) 2015-10-07
EP1553967B1 (fr) 2011-05-18
EP1553967A1 (fr) 2005-07-20
HK1074402A1 (en) 2005-11-11
US7655676B2 (en) 2010-02-02
AU2003242647A1 (en) 2003-12-31
CA2489705C (fr) 2012-08-14
ES2364269T3 (es) 2011-08-30
DK1553967T3 (da) 2011-08-29
SI1553967T1 (sl) 2011-07-29
KR20050026401A (ko) 2005-03-15
PT1553967E (pt) 2011-08-01

Similar Documents

Publication Publication Date Title
Jappe Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy
US8420627B2 (en) Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
JP2005239705A (ja) 局所的抗菌性製剤
JPH10509437A (ja) 防臭、抗菌及び保存剤組成物並びにそれらを使用する方法
KR20140117379A (ko) Dgla, 15-ohepa 및/또는 15-hetre를 포함하는 항미생물 조성물 및 그의 사용 방법
WO1999059580A1 (fr) Agents preventifs/therapeutiques pour les affections cutanees
JP2005247827A (ja) 酒さの治療のための局所用製剤
US20140199413A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
AU2003242647B2 (en) Use of amide derivative of GE 2270 factor A3 for the treatment of acne
JP2003521510A (ja) 抗菌剤としてのレチノイドタイプの化合物の使用
US20190175558A1 (en) Topical pharmaceutical compositions for treatment of tissue damage
PT1515710E (pt) Método de tratamento de rosácea por aplicação tópica de um derivado de ciclo-hexano
JP2017501232A (ja) 局所アラントインを使用したケロイド低減
ES2971823T3 (es) Mejora de las acciones antibacterianas de un antibiótico depsipeptídico mediante cantidades sinérgicas de ácido bórico
WO2004093853A2 (fr) Procede pour inhiber la croissance de bacteries et de champignons pathogenes et composition microbicide
JP7092498B2 (ja) 尿かぶれ改善剤
Tak et al. Comparative evaluation of efficacy of 10% povidone iodine gel with 2% metronidazole and 1% ornidazole with 0.25% chlorhexidine gel as local drug delivery system in adjunt to nonsurgical periodontal therapy in chronic periodontitis: A randomized, single blind, split-mouth study
JP2019214529A (ja) デプシペプチド系抗生物質を含有する外用組成物
JPH05271052A (ja) 尋常性ザ瘡治療用ローション
Kircik Combination therapy considerations in acne vulgaris

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 04 JAN 2007 TO 04 MAY 2007 IN WHICH TO GAIN ACCEPTANCE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO REQUEST EXAMINATION HAS BEEN EXTENDED TO 04 MAY 2007.

PC1 Assignment before grant (sect. 113)

Owner name: NAICONS S.C.A.R.L.

Free format text: FORMER APPLICANT(S): VICURON PHARMACEUTICALS INC.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired